Samsung Biologics Targets Global Dominance with $1.8 Billion Acquisition of PolyPeptide Group
In a strategic maneuver that signals a seismic shift in the Contract Development and Manufacturing Organization (CDMO) landscape, Samsung Biologics...
acquisition
From Fringe to Pharma: Eli Lilly’s $3.8B AtaiBeckley Acquisition Signals the Mainstreaming of Psychedelic Medicine
The pharmaceutical landscape is undergoing a profound transformation. Once relegated to the periphery of medical research and hindered by decades...
Novartis Targets Oncology Leadership with $1.5B Acquisition of ADC Innovator Myricx Bio
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...
Merck KGaA Unveils $11.3 Billion Acquisition of Bio-Techne to Reshape Life Sciences Landscape
In a landmark move that promises to redraw the boundaries of the global life sciences sector, Merck KGaA, Darmstadt, Germany,...
AbbVie’s $10.9 Billion Acquisition of Apogee Therapeutics: A Strategic Pivot in the Immunology Arms Race
SAN DIEGO — In a move that signals a significant intensification of the global battle for dominance in the immunology...
GSK Bolsters Oncology Portfolio with $10.6 Billion Acquisition of Nuvalent
In a move that signals a significant shift in its long-term growth strategy, GlaxoSmithKline (GSK) has officially announced a definitive...
